Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daikenchuto for Abdominal Bloating in Female IBS
NCT02074579Phase 2Completed
- Sponsor
- Tsumura & Co.
- Start
- Jul 2014
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in irritable bowel syndrome (IBS) comparing TU-100 with Matching placebo (2 arms). Primary endpoint: Abdominal bloating rating at 4 weeks. Started Jul 2014; status: completed.
02
Drugs
daikenchuto
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT02074579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02074579.